Advancing current understanding on the clinical impact of HIV-1 subtype C diversity
There is still no cure for HIV infection and the extensive viral genetic diversity represents the one of the biggest obstacles to develop an effective therapy…
Ana Santos-Pereira was born in Braga, in 1991, having completed her graduation in Applied Biology and Master’s degree in Molecular Genetics in the same city, at the University of Minho. She recently obtained her PhD in Ageing and Chronic Diseases, also at the University of Minho, which mainly focused on studying the evolution, genetic diversity, and drug resistance mutations of HIV-1 resorting to bioinformatic tools. Currently, Ana continues to investigate the mechanisms of infection and epidemic evolution of HIV-1 and other pathogens, aiming at having a positive impact in society in any way possible with her work.
Ana Santos-Pereira was born in Braga, in 1991, having completed her graduation in Applied Biology and Master’s degree in Molecular Genetics in the same city, at the University of Minho. She recently obtained her PhD in Ageing and Chronic Diseases, also at the University of Minho, which mainly focused on studying the evolution, genetic diversity, and drug resistance mutations of HIV-1 resorting to bioinformatic tools. Currently, Ana continues to investigate the mechanisms of infection and epidemic evolution of HIV-1 and other pathogens, aiming at having a positive impact in society in any way possible with her work.
– Ana’s PhD research resulted in two publications in international magazines (https://www.mdpi.com/1422-
0067/22/10/5304 and https://doi.org/10.1038/s41598-021-02428-3) and a review paper (https://www.mdpi.com/2076-2607/9/1/147) as first author
– Ana also had an active role on spreading these findings in the Portuguese and Brazilian media, including radio, magazines, and television (for example: https://g1.globo.com/sp/sao-carlos-regiao/noticia/2021/06/29/mutacao-do-hiv-e-identificada-por-
pesquisadores-da-ufscar-e-de-universidade-de-portugal.ghtml and https://healthnews.pt/2021/06/25/o-problema-da-resistencia-do-hiv-a-terapia-conclusoes-de-um-estudo-de-larga-escala-no-brasil/?doing_wp_cron=1652088096.6720910072326660156250 )
– Ana had opportunity to present her work in different Brazilian Universities (https://www.diariodareitoria.ufscar.br/ufscar-e-universidade-do-minho-tem-parceria-para-pesquisa-sobre-hiv-no-brasil/ ) in order to establish new collaborations, and in the Congresso da Sociedade Brasileira de DST, VIII Congresso Brasileiro de AIDS e III Congresso Latino Americano IST/HIV/AIDS has a co-author of two publications
– Ana participated in several national and international congresses, incluing in the XXV Congreso Latinoamericano de Microbiología, Paraguai, as Invited Speaker.
– Ana’s work was recognized by the Jury of her PhD defense, through the attribution of the highest classification available at the University of Minho.
There is still no cure for HIV infection and the extensive viral genetic diversity represents the one of the biggest obstacles to develop an effective therapy…
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal